CXCL16 functions as a chemoattractant for Th1 cells and it is considered as a systemic inflammatory marker for COPD (Shashkin et al., 2003; Donnelly and Barnes, 2006; Eagan et al., 2010). This evidence concerns the gene CXCL16 and chronic obstructive pulmonary disease.